Position in ZTS
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$1,022,783
-$1,257,842 QoQ
Shares Held
14,233
-26.2% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#636
of 1,408 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Clearstead Advisors, LLC holds $1,662,942 across 40 Drug Manufacturers - Specialty & Generic names. ZTS ranks #1 (61.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
This page
|
14,233 | $1,022,783 | |
| 2 | HLN |
Haleon plc
|
20,447 | $190,770 | |
| 3 | TEVA |
Teva Pharmaceutical Industries Ltd
|
2,765 | $93,678 | |
| 4 | VTRS |
Viatris Inc
|
4,374 | $69,459 | |
| 5 | NBIX |
Neurocrine Biosciences Inc
|
345 | $58,146 | |
| 6 | ELAN |
Elanco Animal Health Inc
|
2,008 | $49,416 | |
| 7 | RDY |
Dr Reddys Laboratories Ltd
|
3,338 | $48,367 | |
| 8 | HIMS |
Hims & Hers Health, Inc.
|
1,343 | $46,561 |
All Filings in ZTS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,022,783 | 14,233 | Shares | Sole | 2026-08-06 | |
| 2026-03-31 | $2,280,625 | 19,293 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,865,550 | 22,775 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $14,378,281 | 98,266 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $15,837,034 | 101,552 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $15,655,745 | 95,085 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $13,857,359 | 85,051 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $16,169,062 | 82,757 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $12,914,973 | 74,498 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $519,136 | 3,068 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $588,754 | 2,983 | Shares | Sole | 2024-02-12 | |
| 2023-09-30 | $563,173 | 3,237 | Shares | Sole | 2023-11-07 | |
| 2023-06-30 | $571,392 | 3,318 | Shares | Sole | 2023-08-07 | |
| 2023-03-31 | $349,024 | 2,097 | Shares | Sole | 2023-05-09 | |
| 2022-12-31 | $218,359 | 1,490 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $231,480 | 1,561 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $320,402 | 1,864 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $333,427 | 1,768 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $386,055 | 1,582 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $260,924 | 1,344 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $317,743 | 1,705 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $213,227 | 1,354 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $113,202 | 684 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $118,239 | 715 | Shares | Sole | 2020-11-12 | |
| 2020-06-30 | $93,735 | 684 | Shares | Sole | 2020-08-11 | |
| 2020-03-31 | $80,499 | 684 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||